IGBA - International Generic and Biosimilar medicines Association’s Post

hoping to see many of you at the upcoming Biosimilars LatAm - Europe Online Forum! Watch the video below

Day 2 of BioAsia 2024 was a success! Industry leaders gathered to share insights and trends, making for an engaging and informative day. The panel discussion on the evolving role of India in the pharma services industry sparked thought-provoking conversation, while the CEO conclave on geopolitical imperatives to reorganize drug supply chain was equally insightful. In addition, I had the opportunity to interact with booths and build valuable contacts. Looking forward to implementing the knowledge gained from this event. #BioAsia2024 #PharmaIndustry #IndustryLeaders #Networking #pharmaceuticals #eosintelligence

Register for our webinar: https://lnkd.in/e3RJbR6f The pharmaceutical market in China continues to show significant growth, while China-based research and development operations provide a globally important technology ecosystem. This landscape, combined with shifting geopolitical tensions and changing regulations, has created new challenges for pharmaceutical companies. Hear from our panel, including Lisa LeCointe-Cephas, former Senator Richard Burr, Ting Xiao, Vanessa J. Le, and Peng Tao on the latest developments in Chinese innovation and drug development, regulatory reform, market access, and investigations. #LifeSciences #Pharmaceutical #Technology #DrugDevelopment

Submit Your Research for #Pharma_Europe 2025 – Call for Proposals Now Open ! We are excited to announce the Call for #Proposals for the 35th Annual European Pharma Congress on March 10-11, 2025, in the historic and inspiring city of Rome, Italy. Join us in shaping the future of #pharmaceuticals by sharing your research, insights, and #innovative solutions with a global audience of experts, researchers, and industry leaders. Don’t miss the chance to contribute to Europe’s leading forum for #pharmaceutical_research and development. #Submissions will be reviewed by a #panel of experts to ensure a high-quality program. For more Details please visit : https://cutt.ly/IeDzDqIl #PharmaEurope2025 #PharmaCongress #SubmitProposals #EuropeanPharma #Callforabstracts #Rome2025 #Pharmaceutical_Innovation #PharmaGrowth #FutureOfPharma #PharmaConference #DrugDiscovery #RegenerativeMedicine #PharmaLeaders #PharmaOpportunities #PharmaIndustry #RomeConference

Register for our webinar: http://spr.ly/6045qX8VT The pharmaceutical market in China continues to show significant growth, while China-based research and development operations provide a globally important technology ecosystem. This landscape, combined with shifting geopolitical tensions and changing regulations, has created new challenges for pharmaceutical companies. Hear from our panel, including Lisa LeCointe-Cephas, former Senator Richard Burr, Ting Xiao, Vanessa J. Le, and Peng Tao on the latest developments in Chinese innovation and drug development, regulatory reform, market access, and investigations. #LifeSciences #Pharmaceutical #Technology #DrugDevelopment

Register for our webinar: http://spr.ly/6045qX8VT The pharmaceutical market in China continues to show significant growth, while China-based research and development operations provide a globally important technology ecosystem. This landscape, combined with shifting geopolitical tensions and changing regulations, has created new challenges for pharmaceutical companies. Hear from our panel, including Lisa LeCointe-Cephas, former Senator Richard Burr, Ting Xiao, Vanessa J. Le, and Peng Tao on the latest developments in Chinese innovation and drug development, regulatory reform, market access, and investigations. #LifeSciences #Pharmaceutical #Technology #DrugDevelopment

Eri Sekine, Executive Vice President, CMIC Group, will be chairing a Forum Presentation at DIA on Tuesday, June 18th at 1:15 pm. The session, titled “Enabling Patient Access Worldwide Including Japan or Other Countries to Innovative Drugs Through Global Development Strategy,” will delve into strategies for maximizing global patient access and business opportunities through effective global development approaches. 📅 Date and Time: Tuesday, June 18th at 1:15 pm 📌 Experts from pharma and biotech sectors will share insights on: - Maximizing the value of innovative products for the global market - Applying clinical development strategies to expand the target market effectively - Influencing regulators, industry, and trial sites to improve the local environment for global simultaneous development Visit booth #1107 after the presentation to ask any questions and continue the discussion. #DIA2024 #GlobalDevelopment #PharmaInnovation #PatientAccess #CMICGroup #Pharmaceuticals #Biotech #ClinicalDevelopment

The LATAM pharmaceutical market is on the rise, valued at $98 billion and poised for a remarkable 10.1% growth— underscoring the region’s potential as a hub for innovation, local manufacturing, and biotechnology. However, challenges such as technology gaps and supply chain constraints remain. From Data to Artificial Intelligence: How is Latin America Growing? Join our upcoming Summit LATAM hosted by Clarivate in partnership with ABIQUIFI, on Oct 7 in Milan to foster dialogue among key stakeholders in the health sector, from private entities to regulatory agencies. Don't miss this chance to be part of a transformative conversation. Register | Portuguese: https://lnkd.in/eiz59Kqc Register | Spanish: https://lnkd.in/epj6ebqJ #ArtificialIntelligence #LATAM #Innovation #Pharmaceuticals #LATAMSummit #Regulatory #DataInnovation

What does your board need to know about the pharmaceutical landscape in China? For those interested, we are having a CLE webinar on Nov 13th at 10am ET. Topics include government incentives, go-to-market regulatory considerations, the 2024 election impact, BIOSECURE Act ramifications, and Chinese pharma investigations and anti-corruption campaign.

Biopharma is facing increasing pressure to consistently deliver new, innovative products to patients, gain a competitive advantage, and meet greater stakeholder expectations. We're exploring how organisations need to change the way they operate, at both an enterprise as well as partnership level, to fully realise the potential of strategic partnerships and maximise impact for patients. Later this month, we'll be attending Patients as Partners Europe and the NEXT conference in Dubrovnik, as well as sharing our insights on how pharma companies can strategically partner with other organisations, healthcare professionals and patients to leverage their strengths, share risks, and unlock innovation. Find out more: https://ow.ly/xTzz50RvRMX #biotech #biopharma #pharma #lifesciences #pharmaceuticals #biotechnology Kate Moss (nee Watkins) Samantha Sierwald Joshua Elliott Chris Maxted